Key facts
- Dandelion Health’s last known valuation is $62.0M (Feb 2024).
- It has raised $15.9M across 1 recorded rounds; the latest was Early Stage VC ($15.9M) in Feb 2024.
- Notable investors include Primary Venture Partners, Floating Point, Phoenix Venture Partners, Convergent Ventures (San Francisco), Healthier Capital — 7 tracked in total.
- Dandelion Health has filed 1 Form D with the SEC, most recently Mar 2024 ($15.9M sold to 23 investors).
- Status: Privately Held (backing).
Leadership
- Elliott GreenChief Executive Officer & Founder
- Kiko WemmerGeneral Manager & Vice President
- Nicholas GossenHead
- Ziad ObermeyerChief Scientific Officer & Founder
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Dandelion Health
Funding rounds
1 roundsAbout Dandelion Health
Provider of a real-world patient data and clinical AI platform designed to accelerate healthcare AI development and commercialization. The company integrates de-identified multimodal clinical data from millions of patient records into regulatory-grade, research-ready datasets, enabling life sciences companies and AI developers to design and validate AI models and generate real-world evidence to bring safer, more effective AI-enabled therapies and tools to market faster.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 20
- Website
- dandelionhealth.ai/
- Ownership
- Privately Held (backing)
Dandelion Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dandelion Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dandelion Health in its N-PORT filings yet. We sweep new filings monthly.